169 related articles for article (PubMed ID: 36835134)
21. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
[TBL] [Abstract][Full Text] [Related]
22. Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide‑conjugated BSA.
Heo CK; Lim WH; Park I; Choi YS; Lim KJ; Cho EW
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36321789
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
[TBL] [Abstract][Full Text] [Related]
24. Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi-institutional study.
Okada R; Otsuka Y; Yokosuka O; Kato N; Imazaki F; Hoshino I; Sugiura N; Mizumoto H; Azemoto R; Kato K; Shimada H
Oncol Lett; 2022 Oct; 24(4):367. PubMed ID: 36238856
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma.
Wang K; Chen Y; Liu S; Qiu S; Gao S; Huang X; Zhang J; Peng X; Qiani W; Zhang JY
Int J Immunopathol Pharmacol; 2009; 22(3):735-43. PubMed ID: 19822090
[TBL] [Abstract][Full Text] [Related]
26. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.
Okada R; Otsuka Y; Wakabayashi T; Shinoda M; Aoki T; Murakami M; Arizumi S; Yamamoto M; Aramaki O; Takayama T; Wakiyama S; Yanaga K; Amikura K; Kaneko H; Shimada H
Int J Cancer; 2020 Nov; 147(9):2578-2586. PubMed ID: 32574375
[TBL] [Abstract][Full Text] [Related]
27. Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma.
Nomura F; Sogawa K; Noda K; Seimiya M; Matsushita K; Miura T; Tomonaga T; Yoshitomi H; Imazeki F; Takizawa H; Mogushi K; Miyazaki M; Yokosuka O
Biochem Biophys Res Commun; 2012 May; 421(4):837-43. PubMed ID: 22554520
[TBL] [Abstract][Full Text] [Related]
28. Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.
Wang Z; Gou W; Liu M; Sang W; Chu H; Zhang W
Med Sci Monit; 2015 Oct; 21():3209-15. PubMed ID: 26494212
[TBL] [Abstract][Full Text] [Related]
29. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
[TBL] [Abstract][Full Text] [Related]
30. Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma.
Looi KS; Nakayasu ES; Diaz RA; Tan EM; Almeida IC; Zhang JY
J Proteome Res; 2008 Sep; 7(9):4004-12. PubMed ID: 18672925
[TBL] [Abstract][Full Text] [Related]
31. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
[TBL] [Abstract][Full Text] [Related]
32. The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma.
Zhu W; Shi P; Liang A; Zhu Y; Fu J; Yuan S; Wu X
BMC Cancer; 2022 Oct; 22(1):1061. PubMed ID: 36241994
[TBL] [Abstract][Full Text] [Related]
33. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
Ying X; Zhao Y; Wang JL; Zhou X; Zhao J; He CC; Guo XJ; Jin GH; Wang LJ; Zhu Q; Han SX
Oncol Rep; 2014 Oct; 32(4):1550-6. PubMed ID: 25109745
[TBL] [Abstract][Full Text] [Related]
34. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway.
Liu W; Li X; Chu ES; Go MY; Xu L; Zhao G; Li L; Dai N; Si J; Tao Q; Sung JJ; Yu J
Hepatology; 2011 Mar; 53(3):843-53. PubMed ID: 21319196
[TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of autoantibodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma.
Raedle J; Oremek G; Truschnowitsch M; Lorenz M; Roth WK; Caspary WF; Zeuzem S
Eur J Cancer; 1998 Jul; 34(8):1198-203. PubMed ID: 9849479
[TBL] [Abstract][Full Text] [Related]
36. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma.
El-Shal AS; Zidan HE; Rashad NM; Wadea FM
Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666
[TBL] [Abstract][Full Text] [Related]
37. An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma.
Hong Y; Long J; Li H; Chen S; Liu Q; Zhang B; He X; Wang Y; Li H; Li Y; Zhang T; Lu C; Yan H; Zhang M; Li Q; Cao B; Bai Z; Wang J; Zhang Z; Zhu S; Zheng J; Ou X; Ma H; Jia J; You H; Wang S; Huang J
EBioMedicine; 2015 May; 2(5):438-46. PubMed ID: 26137588
[TBL] [Abstract][Full Text] [Related]
38. Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Raedle J; Roth WK; Oremek G; Caspary WF; Zeuzem S
Dig Dis Sci; 1995 Dec; 40(12):2587-94. PubMed ID: 8536517
[TBL] [Abstract][Full Text] [Related]
39. Autoantibody signature in hepatocellular carcinoma using seromics.
Zhang S; Liu Y; Chen J; Shu H; Shen S; Li Y; Lu X; Cao X; Dong L; Shi J; Cao Y; Wang X; Zhou J; Liu Y; Chen L; Fan J; Ding G; Gao Q
J Hematol Oncol; 2020 Jul; 13(1):85. PubMed ID: 32616055
[TBL] [Abstract][Full Text] [Related]
40. Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma.
Lu F; Shah PA; Rao A; Gifford-Hollingsworth C; Chen A; Trey G; Soryal M; Talat A; Aslam A; Nasir B; Choudhry S; Ishtiaq R; Sanoff H; Conteh LF; Noonan A; Hu KQ; Schmidt C; Fu M; Civan J; Xiao G; Lau DT; Lu X
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00271. PubMed ID: 33512798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
